Pinned Tweet
Hey @DipWheeler as a testicle, butthole, and fartcoin bull myself, I think it’s time you look into boner coin backed by hims on longxyz
Long and hard
Scrotoshi Sackamoto retweeted
No one:
Bonershire Harderway: $BONER 6.9B hard money
During times of uncertainty, investors will flock to hard money.
boner-coin:native is #1 trending on FOMO.
Wait until Stanley Druckenmiller hears about boner coin.
Wood morning.
Yesterday, HHS issued a draft interim policy that opened a safer, regulated path for peptides including BPC-157 and TB-500. This is a big step forward for access to innovation for more people, and over the last 2 years, we’ve been investing in the domestic infrastructure necessary for this exact moment.
With Peptides+, clinician-led protocols built by the experts in the field plus a world-class infrastructure comes together in the one of the only companies that can deliver quality access to these newly eligible treatments. Through our US based facilities, we’ll be able to offer eligible customers access to the newly allowed peptides made 100% from start to finish in the US, with ongoing clinical support and an entirely US-based supply chain they can trust.
Get an early look at what’s coming and sign up to be among the first in line to be in the know as we begin to roll this out: hims.com/peptides-plus
Important disclaimers here: news.hims.com/disclaimers/ca…
Scrotoshi Sackamoto retweeted
Stanley Druckenmiller bullish on onchain finance? Sounds like it's time to purchase more boner coin.
Scrotoshi Sackamoto retweeted
Read more from me here on how we’ve built this offering: news.hims.com/newsroom/expan…
Scrotoshi Sackamoto retweeted
Yesterday, HHS issued a draft interim policy that opened a safer, regulated path for peptides including BPC-157 and TB-500. This is a big step forward for access to innovation for more people, and over the last 2 years, we’ve been investing in the domestic infrastructure necessary for this exact moment.
With Peptides+, clinician-led protocols built by the experts in the field plus a world-class infrastructure comes together in the one of the only companies that can deliver quality access to these newly eligible treatments. Through our US based facilities, we’ll be able to offer eligible customers access to the newly allowed peptides made 100% from start to finish in the US, with ongoing clinical support and an entirely US-based supply chain they can trust.
Get an early look at what’s coming and sign up to be among the first in line to be in the know as we begin to roll this out: hims.com/peptides-plus
Important disclaimers here: news.hims.com/disclaimers/ca…
Scrotoshi Sackamoto retweeted
Soon we will see the moon $boner


























